Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

First in Human Trial of TAS266 in Patients With Advanced Solid Tumors

This study has been terminated.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: February 1, 2012
Last updated: December 10, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)